Earnings To Watch: Scandinavian Astor Group AB (NGM:ASTOR) Q2 2026 -- GF Value Sees 229% UpsideGuruFocus.com
Stock, pipeline and biotech catalyst intelligence
Latest coverage
Company profile
NGM Biopharmaceuticals is a biotechnology company in the healthcare sector.
Company profile compiled from available company records. Catalyst dates can change and should be confirmed against the linked primary source.
Page updated Aug 23, 2026 · Yahoo quotes cached for one minute; reference data may be used when a live field is unavailable.